{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T12:00:14Z","timestamp":1776168014384,"version":"3.50.1"},"reference-count":84,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30CA008748"],"award-info":[{"award-number":["P30CA008748"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surgpath.theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgical Pathology Clinics"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.path.2025.10.001","type":"journal-article","created":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T20:37:26Z","timestamp":1772656646000},"page":"e1-e22","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"S","title":["Breast Papillary Neoplasms"],"prefix":"10.1016","volume":"18","author":[{"given":"Theodore","family":"Vougiouklakis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edi","family":"Brogi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.path.2025.10.001_bib1","series-title":"Breast tumours","year":"2019"},{"key":"10.1016\/j.path.2025.10.001_bib2","doi-asserted-by":"crossref","first-page":"8643","DOI":"10.1245\/s10434-021-10188-7","article-title":"Upgrade rate and predictive factors for breast benign intraductal papilloma diagnosed at biopsy: a meta-analysis","volume":"28","author":"Zhang","year":"2021","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.path.2025.10.001_bib3","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1097\/00000478-200606000-00001","article-title":"An analysis of breast cancer risk in women with single, multiple, and atypical papilloma","volume":"30","author":"Lewis","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.path.2025.10.001_bib4","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1053\/hupa.2003.25","article-title":"Clinicopathologic analysis of breast lesions associated with multiple papillomas","volume":"34","author":"Ali-Fehmi","year":"2003","journal-title":"Hum Pathol"},{"key":"10.1016\/j.path.2025.10.001_bib5","doi-asserted-by":"crossref","first-page":"264","DOI":"10.2214\/AJR.11.7922","article-title":"Papillary lesions of the breast: MRI, ultrasound, and mammographic appearances","volume":"198","author":"Eiada","year":"2012","journal-title":"AJR. American journal of roentgenology"},{"key":"10.1016\/j.path.2025.10.001_bib6","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/j.crad.2008.02.012","article-title":"Radiological appearances of papillary breast lesions","volume":"63","author":"Brookes","year":"2008","journal-title":"Clin Radiol"},{"key":"10.1016\/j.path.2025.10.001_bib7","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1245\/s10434-010-1403-7","article-title":"Are we overtreating papillomas diagnosed on core needle biopsy?","volume":"18","author":"Cyr","year":"2011","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.path.2025.10.001_bib8","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1097\/PAS.0b013e318243fa00","article-title":"Papillary lesions of the breast: impact of breast pathology subspecialization on core biopsy and excision diagnoses","volume":"36","author":"Jakate","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.path.2025.10.001_bib9","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/(SICI)1097-0142(19960715)78:2<258::AID-CNCR11>3.0.CO;2-V","article-title":"Subsequent breast carcinoma risk after biopsy with atypia in a breast papilloma","volume":"78","author":"Page","year":"1996","journal-title":"Cancer"},{"key":"10.1016\/j.path.2025.10.001_bib10","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1245\/s10434-007-9780-2","article-title":"Surgical follow-up and clinical presentation of 142 breast papillary lesions diagnosed by ultrasound-guided core-needle biopsy","volume":"15","author":"Rizzo","year":"2008","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.path.2025.10.001_bib11","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/pin.12285","article-title":"Intraductal papillomas on core biopsy can be upgraded to malignancy on subsequent excisional biopsy regardless of the presence of atypical features","volume":"65","author":"Shiino","year":"2015","journal-title":"Pathol Int"},{"key":"10.1016\/j.path.2025.10.001_bib12","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1245\/s10434-011-1617-3","article-title":"Papillary lesions initially diagnosed at ultrasound-guided vacuum-assisted breast biopsy: rate of malignancy based on subsequent surgical excision","volume":"18","author":"Chang","year":"2011","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.path.2025.10.001_bib13","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1007\/s00330-009-1649-2","article-title":"Risk of carcinoma after subsequent excision of benign papilloma initially diagnosed with an ultrasound (US)-Guided 14-gauge core needle biopsy: a prospective observational study","volume":"20","author":"Chang","year":"2010","journal-title":"Eur Radiol"},{"key":"10.1016\/j.path.2025.10.001_bib14","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1245\/s10434-012-2846-9","article-title":"Management of benign intraductal solitary papilloma diagnosed on core needle biopsy","volume":"20","author":"Swapp","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.path.2025.10.001_bib15","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1245\/s10434-014-4091-x","article-title":"Papilloma on core biopsy: excision vs. observation","volume":"22","author":"Nakhlis","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.path.2025.10.001_bib16","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.1002\/cncr.30118","article-title":"Breast intraductal papillomas without atypia in radiologic-pathologic concordant core-needle biopsies: rate of upgrade to carcinoma at excision","volume":"122","author":"Pareja","year":"2016","journal-title":"Cancer"},{"key":"10.1016\/j.path.2025.10.001_bib17","doi-asserted-by":"crossref","first-page":"410","DOI":"10.4048\/jbc.2016.19.4.410","article-title":"Predictive factors for upgrading patients with benign breast papillary lesions using a core needle biopsy","volume":"19","author":"Hong","year":"2016","journal-title":"J Breast Cancer"},{"key":"10.1016\/j.path.2025.10.001_bib18","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1245\/s10434-016-5144-0","article-title":"Asymptomatic benign papilloma without atypia diagnosed at ultrasonography-guided 14-Gauge core needle biopsy: which subgroup can be managed by observation?","volume":"23","author":"Kim","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.path.2025.10.001_bib19","doi-asserted-by":"crossref","first-page":"80","DOI":"10.4048\/jbc.2018.21.1.80","article-title":"Benign intraductal papilloma without atypia on core needle biopsy has a low rate of upgrading to malignancy after excision","volume":"21","author":"Han","year":"2018","journal-title":"J Breast Cancer"},{"key":"10.1016\/j.path.2025.10.001_bib20","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ejso.2017.10.214","article-title":"Management of benign papilloma without atypia diagnosed at ultrasound-guided core needle biopsy: scoring system for predicting malignancy","volume":"44","author":"Ahn","year":"2018","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.path.2025.10.001_bib21","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1007\/s00268-019-05047-2","article-title":"Treatment and outcome of 341 papillary breast lesions","volume":"43","author":"Chen","year":"2019","journal-title":"World J Surg"},{"key":"10.1016\/j.path.2025.10.001_bib22","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.clinimag.2018.04.021","article-title":"Concordant, non-atypical breast papillomas do not require surgical excision: a 10-year multi-institution study and review of the literature","volume":"51","author":"Grimm","year":"2018","journal-title":"Clin Imag"},{"key":"10.1016\/j.path.2025.10.001_bib23","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.amjsurg.2020.01.040","article-title":"Upgrade rate of intraductal papilloma without atypia on breast core needle biopsy: a clinical, radiological and pathological correlation study","volume":"220","author":"Genco","year":"2020","journal-title":"Am J Surg"},{"key":"10.1016\/j.path.2025.10.001_bib24","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.acra.2010.01.001","article-title":"Is surgical excision of core biopsy proven benign papillomas of the breast necessary?","volume":"17","author":"Bennett","year":"2010","journal-title":"Acad Radiol"},{"key":"10.1016\/j.path.2025.10.001_bib25","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1245\/s10434-020-09215-w","article-title":"The incidence of adjacent synchronous invasive carcinoma and\/or Ductal Carcinoma in situ in patients with intraductal papilloma without atypia on core biopsy: results from a prospective multi-institutional registry (TBCRC 034)","volume":"28","author":"Nakhlis","year":"2021","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.path.2025.10.001_bib26","unstructured":"Kulkarni S, Lizarraga I. Resource guide: surgical management of benign or high-risk lesions. 2025. Available at: https:\/\/www.breastsurgeons.org\/docs\/statements\/asbrs-high-risk-lesions.pdf."},{"key":"10.1016\/j.path.2025.10.001_bib27","article-title":"European guidelines for the diagnosis, treatment and follow-up of breast lesions with uncertain malignant potential (B3 lesions) developed jointly by EUSOMA, EUSOBI, ESP (BWG) and ESSO","volume":"50","author":"Rubio","year":"2024","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.path.2025.10.001_bib28","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1097\/00000478-200608000-00011","article-title":"Intracystic papillary carcinomas of the breast: a reevaluation using a panel of myoepithelial cell markers","volume":"30","author":"Collins","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.path.2025.10.001_bib29","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/0046-8177(94)90250-X","article-title":"Intraductal (intracystic) papillary carcinoma of the breast and its variants: a clinicopathological study of 77 cases","volume":"25","author":"Lefkowitz","year":"1994","journal-title":"Hum Pathol"},{"key":"10.1016\/j.path.2025.10.001_bib30","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/1097-0142(19830701)52:1<14::AID-CNCR2820520104>3.0.CO;2-N","article-title":"Intracystic papillary carcinoma of the breast. After mastectomy, radiotherapy or excisional biopsy alone","volume":"52","author":"Carter","year":"1983","journal-title":"Cancer"},{"key":"10.1016\/j.path.2025.10.001_bib31","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1186\/s13000-014-0227-3","article-title":"Ductal carcinoma in situ of the breast: correlation between histopathological features and age of patients","volume":"9","author":"Perez","year":"2014","journal-title":"Diagn Pathol"},{"key":"10.1016\/j.path.2025.10.001_bib32","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1097\/PAS.0000000000001340","article-title":"Papillary lesions of the Male breast: a study of 117 cases and brief review of the literature demonstrate a broad clinicopathologic spectrum","volume":"44","author":"Zhong","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.path.2025.10.001_bib33","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.amjsurg.2007.06.016","article-title":"Therapeutic management of intracystic papillary carcinoma of the breast: the roles of radiation and endocrine therapy","volume":"194","author":"Fayanju","year":"2007","journal-title":"Am J Surg"},{"key":"10.1016\/j.path.2025.10.001_bib34","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.breast.2016.01.003","article-title":"Intracystic papillary carcinoma of the breast: a SEER database analysis of implications for therapy","volume":"27","author":"Mogal","year":"2016","journal-title":"Breast (Edinburgh, Scotland)"},{"key":"10.1016\/j.path.2025.10.001_bib35","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1097\/PAS.0b013e31821b3f65","article-title":"Encapsulated papillary carcinoma of the breast: an invasive tumor with excellent prognosis","volume":"35","author":"Rakha","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.path.2025.10.001_bib36","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.prp.2018.01.006","article-title":"Intracystic papillary carcinoma of the breast: experience of a major Chinese cancer center","volume":"214","author":"Zhang","year":"2018","journal-title":"Pathol Res Pract"},{"key":"10.1016\/j.path.2025.10.001_bib37","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1111\/his.12591","article-title":"High-grade encapsulated papillary carcinoma of the breast: an under-recognized entity","volume":"66","author":"Rakha","year":"2015","journal-title":"Histopathology"},{"key":"10.1016\/j.path.2025.10.001_bib38","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1309\/XG7TPQ16DMJAV8P1","article-title":"Myoepithelial cell staining patterns of papillary breast lesions: from intraductal papillomas to invasive papillary carcinomas","volume":"123","author":"Hill","year":"2005","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.path.2025.10.001_bib39","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1097\/PAS.0b013e3182142cf3","article-title":"Intracystic papillary carcinomas of the breast are more similar to in situ carcinomas than to invasive carcinoma","volume":"35","author":"Bhargava","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.path.2025.10.001_bib40","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1309\/AJCP8A2UVLCYGTPU","article-title":"Are encapsulated papillary carcinomas of the breast in situ or invasive? A basement membrane study of 27 cases","volume":"131","author":"Esposito","year":"2009","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.path.2025.10.001_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/PAS.0b013e3181fbe20a","article-title":"Intracystic papillary carcinoma of the breast: an in situ or invasive tumor? Results of immunohistochemical analysis and clinical follow-up","volume":"35","author":"Wynveen","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.path.2025.10.001_bib42","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/tbj.14153","article-title":"Encapsulated papillary carcinoma with and without frank invasion: comparison of clinicopathologic features and role of axillary staging","volume":"27","author":"Jackson","year":"2021","journal-title":"Breast J"},{"key":"10.1016\/j.path.2025.10.001_bib43","doi-asserted-by":"crossref","first-page":"11408","DOI":"10.1002\/cam4.5855","article-title":"Encapsulated papillary carcinoma of the breast: an institutional case series and literature review","volume":"12","author":"Tan","year":"2023","journal-title":"Cancer Med"},{"key":"10.1016\/j.path.2025.10.001_bib44","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1200\/JCO-25-00099","article-title":"Sentinel lymph node biopsy in early-stage breast cancer: ASCO guideline update","volume":"43","author":"Park","year":"2025","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.path.2025.10.001_bib45","unstructured":"Surgeons, A.S.o.B. Axillary management for patients with in-situ and invasive breast cancer: a concise overview. 2022. Available at: https:\/\/www.breastsurgeons.org\/docs\/statements\/asbrs-management-of-the-axilla.pdf."},{"key":"10.1016\/j.path.2025.10.001_bib46","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1097\/00000478-199511000-00003","article-title":"Solid papillary carcinoma of the breast. A form of intraductal carcinoma with endocrine differentiation frequently associated with mucinous carcinoma","volume":"19","author":"Maluf","year":"1995","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.path.2025.10.001_bib47","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1097\/00000478-199608000-00002","article-title":"Endocrine ductal carcinoma in situ (E-DCIS) of the breast: a form of low-grade DCIS with distinctive clinicopathologic and biologic characteristics","volume":"20","author":"Tsang","year":"1996","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.path.2025.10.001_bib48","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.breast.2015.12.015","article-title":"Solid papillary carcinoma of the breast: a special entity needs to be distinguished from conventional invasive carcinoma avoiding over-treatment","volume":"26","author":"Guo","year":"2016","journal-title":"Breast"},{"key":"10.1016\/j.path.2025.10.001_bib49","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/j.1365-2559.2007.02849.x","article-title":"Loss of myoepithelium is variable in solid papillary carcinoma of the breast","volume":"51","author":"Nicolas","year":"2007","journal-title":"Histopathology"},{"key":"10.1016\/j.path.2025.10.001_bib50","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1007\/BF03033706","article-title":"\u201cRevertant\u201d mammary solid papillary carcinoma in lymph node metastasis","volume":"8","author":"Cserni","year":"2002","journal-title":"Pathol Oncol Res"},{"key":"10.1016\/j.path.2025.10.001_bib51","doi-asserted-by":"crossref","DOI":"10.1177\/10668969251339807","article-title":"Morphologically in situ solid papillary carcinoma of the breast with lymph node and lung metastasis: a rare case report and literature review","author":"Matar","year":"2025","journal-title":"Int J Surg Pathol"},{"key":"10.1016\/j.path.2025.10.001_bib52","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1136\/jclinpath-2020-207052","article-title":"Neuroendocrine tumours of the breast: a genomic comparison with mucinous breast cancers and neuroendocrine tumours of other anatomic sites","volume":"75","author":"Pareja","year":"2022","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.path.2025.10.001_bib53","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1038\/modpathol.2009.112","article-title":"Mucinous and neuroendocrine breast carcinomas are transcriptionally distinct from invasive ductal carcinomas of no special type","volume":"22","author":"Weigelt","year":"2009","journal-title":"Mod Pathol"},{"key":"10.1016\/j.path.2025.10.001_bib54","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.humpath.2006.02.016","article-title":"Solid papillary ductal carcinoma in situ versus usual ductal hyperplasia in the breast: a potentially difficult distinction resolved by cytokeratin 5\/6","volume":"37","author":"Rabban","year":"2006","journal-title":"Hum Pathol"},{"key":"10.1016\/j.path.2025.10.001_bib55","doi-asserted-by":"crossref","DOI":"10.1177\/10668969251343222","article-title":"In situ encapsulated\/solid papillary breast carcinoma with lobular differentiation","author":"Molina","year":"2025","journal-title":"Int J Surg Pathol"},{"key":"10.1016\/j.path.2025.10.001_bib56","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1007\/s12282-021-01285-2","article-title":"New variant of breast-invasive lobular carcinoma with solid and encapsulated papillary carcinoma growth pattern","volume":"28","author":"Li","year":"2021","journal-title":"Breast Cancer"},{"key":"10.1016\/j.path.2025.10.001_bib57","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s00428-023-03526-5","article-title":"Uncommon invasive lobular carcinoma with papillary architecture-clinicopathologic and molecular characterization with review of the literature","volume":"483","author":"Gessain","year":"2023","journal-title":"Virchows Arch"},{"key":"10.1016\/j.path.2025.10.001_bib58","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1159\/000442884","article-title":"Invasive lobular carcinoma mimicking papillary carcinoma: a report of three cases","volume":"83","author":"Rakha","year":"2016","journal-title":"Pathobiology"},{"key":"10.1016\/j.path.2025.10.001_bib59","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/S0046-8177(98)90422-1","article-title":"LOH at 16p13 is a novel chromosomal alteration detected in benign and malignant microdissected papillary neoplasms of the breast","volume":"29","author":"Lininger","year":"1998","journal-title":"Hum Pathol"},{"key":"10.1016\/j.path.2025.10.001_bib60","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s10549-004-3003-3","article-title":"Papillary lesions of the breast: a molecular progression?","volume":"90","author":"Di Cristofano","year":"2005","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.path.2025.10.001_bib61","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/modpathol.2009.142","article-title":"High prevalence of PIK3CA\/AKT pathway mutations in papillary neoplasms of the breast","volume":"23","author":"Troxell","year":"2010","journal-title":"Mod Pathol"},{"key":"10.1016\/j.path.2025.10.001_bib62","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/j.ajpath.2018.01.005","article-title":"Mutational analysis of AKT1 and PIK3CA in intraductal papillomas of the breast with special reference to cellular components","volume":"188","author":"Mishima","year":"2018","journal-title":"Am J Pathol"},{"issue":"9","key":"10.1016\/j.path.2025.10.001_bib63","article-title":"The genetic architecture of breast papillary lesions as a predictor of progression to carcinoma","volume":"6","author":"Kader","year":"2020","journal-title":"NPJ Breast Cancer"},{"key":"10.1016\/j.path.2025.10.001_bib64","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/path.3032","article-title":"Immunophenotypic and genomic characterization of papillary carcinomas of the breast","volume":"226","author":"Duprez","year":"2012","journal-title":"J Pathol"},{"key":"10.1016\/j.path.2025.10.001_bib65","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1007\/s10549-010-0961-5","article-title":"Papillary carcinoma of the breast: an overview","volume":"122","author":"Pal","year":"2010","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.path.2025.10.001_bib66","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1002\/cncr.23723","article-title":"Intracystic papillary carcinoma: a review of 917 cases","volume":"113","author":"Grabowski","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.path.2025.10.001_bib67","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1016\/j.molonc.2014.06.011","article-title":"Integrative genomic and transcriptomic characterization of papillary carcinomas of the breast","volume":"8","author":"Piscuoglio","year":"2014","journal-title":"Mol Oncol"},{"key":"10.1016\/j.path.2025.10.001_bib68","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1002\/path.4837","article-title":"The genetic landscape of breast carcinomas with neuroendocrine differentiation","volume":"241","author":"Marchi\u00f2","year":"2017","journal-title":"J Pathol"},{"key":"10.1016\/j.path.2025.10.001_bib69","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1093\/jnci\/djy216","article-title":"The genomic landscape of mucinous breast cancer","volume":"111","author":"Pareja","year":"2019","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.path.2025.10.001_bib70","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/his.13043","article-title":"Frequent PIK3CA activating mutations in nipple adenomas","volume":"70","author":"Liau","year":"2017","journal-title":"Histopathology"},{"key":"10.1016\/j.path.2025.10.001_bib71","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1097\/PAS.0000000000002063","article-title":"Nipple adenoma: clinicopathologic characterization of 50 cases","volume":"47","author":"Weigelt","year":"2023","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.path.2025.10.001_bib84","doi-asserted-by":"crossref","first-page":"105857","DOI":"10.1016\/j.humpath.2025.105857","article-title":"Update in lobular breast lesions: pathological diagnosis in the molecular era","volume":"162","author":"Bai","year":"2025","journal-title":"Hum Pathol"},{"key":"10.1016\/j.path.2025.10.001_bib77","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1038\/s41467-018-04128-5","article-title":"Recurrent hotspot mutations in HRAS Q61 and PI3K-AKT pathway genes as drivers of breast adenomyoepitheliomas","volume":"9","author":"Geyer","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.path.2025.10.001_bib78","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1097\/PAS.0000000000001275","article-title":"Adenomyoepitheliomas of the breast frequently harbor recurrent hotspot mutations in PIK3-AKT pathway-related genes and a subset show genetic similarity to salivary gland epithelial-myoepithelial carcinoma","volume":"43","author":"Lubin","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.path.2025.10.001_bib79","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1038\/s41379-020-0552-x","article-title":"Adenomyoepithelial tumors of the breast: molecular underpinnings of a rare entity","volume":"33","author":"Ginter","year":"2020","journal-title":"Mod Pathol"},{"key":"10.1016\/j.path.2025.10.001_bib80","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/s13045-021-01158-3","article-title":"HRAS is a therapeutic target in malignant chemo-resistant adenomyoepithelioma of the breast","volume":"14","author":"Bi\u00e8che","year":"2021","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.path.2025.10.001_bib73","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1038\/s41379-019-0442-2","article-title":"Immunohistochemical analysis of IDH2 R172 hotspot mutations in breast papillary neoplasms: applications in the diagnosis of tall cell carcinoma with reverse polarity","volume":"33","author":"Pareja","year":"2020","journal-title":"Mod Pathol"},{"key":"10.1016\/j.path.2025.10.001_bib74","doi-asserted-by":"crossref","first-page":"7118","DOI":"10.1158\/0008-5472.CAN-16-0298","article-title":"IDH2 mutations define a unique subtype of breast cancer with altered nuclear polarity","volume":"76","author":"Chiang","year":"2016","journal-title":"Cancer Res"},{"key":"10.1016\/j.path.2025.10.001_bib75","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1038\/s41379-018-0047-1","article-title":"Solid papillary carcinoma with reverse polarity of the breast harbors specific morphologic, immunohistochemical and molecular profile in comparison with other benign or malignant papillary lesions of the breast: a comparative study of 9 additional cases","volume":"31","author":"Alsadoun","year":"2018","journal-title":"Mod Pathol"},{"key":"10.1016\/j.path.2025.10.001_bib76","article-title":"Solid-papillary carcinoma with reverse polarity (SPCRP) harboring a novel IDH1 R132C mutation: a case confirming the expected IDH1\/IDH2 dichotomy","volume":"21","author":"Weisman","year":"2020","journal-title":"Hum Pathol: Case Reports"},{"key":"10.1016\/j.path.2025.10.001_bib82","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1097\/DAD.0000000000002276","article-title":"MAML2 gene rearrangement occurs in nearly all hidradenomas: a reappraisal in a series of 20 cases","volume":"44","author":"Russell-Goldman","year":"2022","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.path.2025.10.001_bib83","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.humpath.2017.10.004","article-title":"A novel fusion gene CRTC3-MAML2 in hidradenoma: histopathological significance","volume":"70","author":"Kuma","year":"2017","journal-title":"Hum Pathol"},{"key":"10.1016\/j.path.2025.10.001_bib72","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1097\/00000478-200308000-00008","article-title":"Breast tumor resembling the tall cell variant of papillary thyroid carcinoma: report of 5 cases","volume":"27","author":"Eusebi","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.path.2025.10.001_bib81","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s00428-014-1687-2","article-title":"Immunohistochemical expression of myoepithelial markers in adenomyoepithelioma of the breast: a unique paradoxical staining pattern of high-molecular weight cytokeratins","volume":"466","author":"Moritani","year":"2015","journal-title":"Virchows Arch"}],"container-title":["Surgical Pathology Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875918125000753?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875918125000753?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T11:14:37Z","timestamp":1776165277000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1875918125000753"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":84,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S1875918125000753"],"URL":"https:\/\/doi.org\/10.1016\/j.path.2025.10.001","relation":{},"ISSN":["1875-9181"],"issn-type":[{"value":"1875-9181","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Breast Papillary Neoplasms","name":"articletitle","label":"Article Title"},{"value":"Surgical Pathology Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.path.2025.10.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}